The news that a major cause of inflammatory bowl disease (IBD) has been found has once again put this distressing medical ...
Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...
Ensho Therapeutics has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day ...
Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...
A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...
Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...
A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...
An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...